540737 Stock Overview
Shree Ganesh Remedies Limited engages in the research, development, manufacture, and sale of pharmaceutical drug intermediates and fine chemicals for pharmaceutical industry in India.
Shree Ganesh Remedies Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||₹244.65|
|52 Week High||₹429.55|
|52 Week Low||₹220.00|
|1 Month Change||7.35%|
|3 Month Change||-1.65%|
|1 Year Change||-28.66%|
|3 Year Change||381.55%|
|5 Year Change||n/a|
|Change since IPO||892.29%|
Recent News & Updates
|540737||IN Pharmaceuticals||IN Market|
Return vs Industry: 540737 underperformed the Indian Pharmaceuticals industry which returned -11.3% over the past year.
Return vs Market: 540737 underperformed the Indian Market which returned -1.7% over the past year.
|540737 Average Weekly Movement||5.1%|
|Pharmaceuticals Industry Average Movement||5.1%|
|Market Average Movement||5.9%|
|10% most volatile stocks in IN Market||9.2%|
|10% least volatile stocks in IN Market||3.8%|
Stable Share Price: 540737 is not significantly more volatile than the rest of Indian stocks over the past 3 months, typically moving +/- 5% a week.
Volatility Over Time: 540737's weekly volatility (5%) has been stable over the past year.
About the Company
Shree Ganesh Remedies Limited engages in the research, development, manufacture, and sale of pharmaceutical drug intermediates and fine chemicals for pharmaceutical industry in India. Its pharmaceutical drug intermediates comprise anti-arrhythmic, anti-cancer, anti-depressant, anti-diabetic, anti-diarrheal, anti-fungal, anti-histamine, anti-inflammatory, anti-parasitic, anti-psychotic, anticholinergic, birth-control, cardiovascular, gastrointestinal, neurological disorder, ophthalmic, opioid, and veterinary pharmaceutical ingredient intermediates. The company also offers fine and specialty chemicals, such as agro-chemicals, electronics, flavor and fragrance, life-sciences, and polymer chemicals, as well as other specialty chemicals, including hexamethylendichloride, octamethylendiamine, and suberonitrile for pharmaceutical, agricultural, and chemical applications.
Shree Ganesh Remedies Fundamentals Summary
|540737 fundamental statistics|
Is 540737 overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|540737 income statement (TTM)|
|Cost of Revenue||₹397.88m|
Last Reported Earnings
Jun 30, 2022
Next Earnings Date
|Earnings per share (EPS)||11.60|
|Net Profit Margin||18.26%|
How did 540737 perform over the long term?See historical performance and comparison
0.2%Current Dividend Yield
Is 540737 undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score 1/6
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Below Fair Value
Significantly Below Fair Value
Key Valuation Metric
Which metric is best to use when looking at relative valuation for 540737?
Other financial metrics that can be useful for relative valuation.
|What is 540737's n/a Ratio?|
Price to Earnings Ratio vs Peers
How does 540737's PE Ratio compare to its peers?
|540737 PE Ratio vs Peers|
|Company||PE||Estimated Growth||Market Cap|
540937 Medico Remedies
526953 Venus Remedies
500009 Ambalal Sarabhai Enterprises
540737 Shree Ganesh Remedies
Price-To-Earnings vs Peers: 540737 is expensive based on its Price-To-Earnings Ratio (21.1x) compared to the peer average (17.3x).
Price to Earnings Ratio vs Industry
How does 540737's PE Ratio compare vs other companies in the IN Pharmaceuticals Industry?
Price-To-Earnings vs Industry: 540737 is good value based on its Price-To-Earnings Ratio (21.1x) compared to the Indian Pharmaceuticals industry average (24.1x)
Price to Earnings Ratio vs Fair Ratio
What is 540737's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
|Current PE Ratio||21.1x|
|Fair PE Ratio||n/a|
Price-To-Earnings vs Fair Ratio: Insufficient data to calculate 540737's Price-To-Earnings Fair Ratio for valuation analysis.
Share Price vs Fair Value
What is the Fair Price of 540737 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: 540737 (₹244.65) is trading above our estimate of fair value (₹142.1)
Significantly Below Fair Value: 540737 is trading above our estimate of fair value.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.
Discover undervalued companies
How is Shree Ganesh Remedies forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?
Future Growth Score0/6
Future Growth Score 0/6
Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings
Revenue vs Market
High Growth Revenue
Forecasted Pharmaceuticals & Biotech industry annual growth in earnings
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Shree Ganesh Remedies has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Discover growth companies
How has Shree Ganesh Remedies performed over the past 5 years?
Past Performance Score5/6
Past Performance Score 5/6
Growing Profit Margin
Earnings vs Industry
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: 540737 has high quality earnings.
Growing Profit Margin: 540737's current net profit margins (18.3%) are lower than last year (19.7%).
Past Earnings Growth Analysis
Earnings Trend: 540737's earnings have grown significantly by 23% per year over the past 5 years.
Accelerating Growth: 540737's earnings growth over the past year (37.7%) exceeds its 5-year average (23% per year).
Earnings vs Industry: 540737 earnings growth over the past year (37.7%) exceeded the Pharmaceuticals industry -2.1%.
Return on Equity
High ROE: 540737's Return on Equity (22.6%) is considered high.
Discover strong past performing companies
How is Shree Ganesh Remedies's financial position?
Financial Health Score6/6
Financial Health Score 6/6
Short Term Liabilities
Long Term Liabilities
Financial Position Analysis
Short Term Liabilities: 540737's short term assets (₹449.1M) exceed its short term liabilities (₹150.4M).
Long Term Liabilities: 540737's short term assets (₹449.1M) exceed its long term liabilities (₹4.0M).
Debt to Equity History and Analysis
Debt Level: 540737 is debt free.
Reducing Debt: 540737 has no debt compared to 5 years ago when its debt to equity ratio was 3%.
Debt Coverage: 540737 has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: 540737 has no debt, therefore coverage of interest payments is not a concern.
Discover healthy companies
What is Shree Ganesh Remedies's current dividend yield, its reliability and sustainability?
Dividend Score 1/6
Cash Flow Coverage
Current Dividend Yield
Dividend Yield vs Market
|Shree Ganesh Remedies Dividend Yield vs Market|
|Company (Shree Ganesh Remedies)||0.2%|
|Market Bottom 25% (IN)||0.4%|
|Market Top 25% (IN)||1.6%|
|Industry Average (Pharmaceuticals)||0.9%|
|Analyst forecast in 3 Years (Shree Ganesh Remedies)||n/a|
Notable Dividend: 540737's dividend (0.2%) isn’t notable compared to the bottom 25% of dividend payers in the Indian market (0.36%).
High Dividend: 540737's dividend (0.2%) is low compared to the top 25% of dividend payers in the Indian market (1.59%).
Stability and Growth of Payments
Stable Dividend: 540737 has been paying a dividend for less than 10 years and during this time payments have been volatile.
Growing Dividend: 540737 has only been paying a dividend for 4 years, and since then payments have fallen.
Earnings Payout to Shareholders
Earnings Coverage: With its low payout ratio (4.3%), 540737's dividend payments are thoroughly covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: 540737 is paying a dividend but the company has no free cash flows.
Discover strong dividend paying companies
How experienced are the management team and are they aligned to shareholders interests?
Average board tenure
Chandulal Kothia (59 yo)
Mr. Chandulal Manubhai Kothia is Promoter, Chairman and Managing Director of Shree Ganesh Remedies Limited. Mr. Kothia has experience of more than two decades in the field of Manufacturing of pharmaceutica...
CEO Compensation Analysis
|Chandulal Kothia's Compensation vs Shree Ganesh Remedies Earnings|
|Date||Total Comp.||Salary||Company Earnings|
|Jun 30 2022||n/a||n/a|
|Mar 31 2022||₹10m||₹10m|
|Dec 31 2021||n/a||n/a|
|Sep 30 2021||n/a||n/a|
|Jun 30 2021||n/a||n/a|
|Mar 31 2021||₹6m||₹6m|
|Dec 31 2020||n/a||n/a|
|Sep 30 2020||n/a||n/a|
|Jun 30 2020||n/a||n/a|
|Mar 31 2020||₹5m||₹5m|
|Dec 31 2019||n/a||n/a|
|Sep 30 2019||n/a||n/a|
|Jun 30 2019||n/a||n/a|
|Mar 31 2019||₹3m||₹3m|
|Dec 31 2018||n/a||n/a|
|Sep 30 2018||n/a||n/a|
|Jun 30 2018||n/a||n/a|
|Mar 31 2018||₹5m||₹5m|
Compensation vs Market: Chandulal's total compensation ($USD121.66K) is above average for companies of similar size in the Indian market ($USD44.15K).
Compensation vs Earnings: Chandulal's compensation has increased by more than 20% in the past year.
Experienced Board: 540737's board of directors are considered experienced (3.8 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
|Owner Type||Number of Shares||Ownership Percentage|
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
|Ownership||Name||Shares||Current Value||Change %||Portfolio %|
Shree Ganesh Remedies Limited's employee growth, exchange listings and data sources
- Name: Shree Ganesh Remedies Limited
- Ticker: 540737
- Exchange: BSE
- Founded: 1995
- Industry: Pharmaceuticals
- Sector: Pharmaceuticals & Biotech
- Implied Market Cap: ₹2.937b
- Shares outstanding: 12.01m
- Website: https://www.ganeshremedies.com
Number of Employees
- Shree Ganesh Remedies Limited
- Plot No. 6011
- G.I.D.C Estate
|Ticker||Exchange||Primary Security||Security Type||Country||Currency||Listed on|
|540737||BSE (Mumbai Stock Exchange)||Yes||Equity Shares||IN||INR||Oct 2017|
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2022/10/05 00:00|
|End of Day Share Price||2022/10/04 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.